Do women need different drug doses? What the research says

Most medicines are given at one dose to adults of both sexes. The research suggests that is not always a good fit. This article looks at what studies found about how women's bodies handle drugs, and where the evidence is firm and where it is not.

Higher blood exposure in women

A 2020 review looked at 86 drugs with published sex-difference data. Women had higher blood exposure to 76 of them.

For the 59 drugs with clear side-effect data, higher exposure in women predicted more side effects in women in 88% of cases. The authors note that body weight alone did not explain the difference, and they recommend evidence-based dose reductions for women.

Those 86 are drugs where researchers found published sex-biased pharmacokinetic data, so the review is not a random sample of all medicines. It shows a pattern. It does not prove that any single dose is wrong.

The best-known example: zolpidem

Zolpidem is a sleep medicine. Exposure ran 40 to 50% higher in women than in men at the same dose, and body weight explained only part of that.

After reports of next-morning impairment, the FDA lowered the recommended dose for women in 2013.

How often are women more likely to have side effects?

Reviews often report that women have roughly 1.5 to 2 times the risk of adverse drug reactions. The firmer figure comes from cohort studies cited in the 2020 review: women over 19 were 43 to 69% more likely to have an adverse reaction recorded by their doctor.

Spontaneous side-effect reports are not rates, so they are not used here.

Drugs withdrawn from the market

A 2001 review by the US General Accounting Office found that 8 of the 10 prescription drugs withdrawn from the US market between January 1997 and December 2000 posed greater health risks for women than for men. For four of the eight, higher use among women may explain part of the gap.

The other four caused more adverse events in women even though they were widely prescribed to both women and men. It was a short review, and it covered prescription drugs only.

What the FDA found about dosing advice

An FDA clinical pharmacology review of 300 new drug applications from 1994 to 2000 found 11 drugs with a difference of more than 40% between men and women in how much of the drug reached the blood. None came with sex-specific dosing advice.

That analysis is more than 20 years old, so read it as history. Sex-specific dosing instructions are still rare on US drug labels.

What this does not tell us

• These studies show associations in groups of drugs and people. They do not tell you your own right dose.
• Exposure is how much of a drug reaches the blood. It includes how the body clears the drug, not only how the liver breaks it down.
• If you take a medicine and have questions about your dose, ask a pharmacist or clinician before changing anything.

Frequently asked questions

Do women need different drug doses?

For some drugs, the evidence suggests yes. Zolpidem is the best-known case: the FDA lowered the recommended dose for women in 2013. For most drugs, sex-specific dosing instructions are absent from the label.

Do women have more side effects from medicines?

Reviews often report higher rates in women. Cohort studies cited in a 2020 review found women over 19 were 43 to 69% more likely to have an adverse reaction recorded.

Were most drugs tested only on men?

Many early-phase trials enrolled few women after a 1977 FDA guideline recommended leaving women of childbearing potential out. The guideline was reversed in 1993.

Related reading

• Why women were left out of clinical trials, and what changed
• Women's health research funding: the gap in numbers
• Gender gaps in care: from the emergency room to heart procedures
• How women entered medicine, and what doctors are still taught
• The women's health research gap: what the evidence shows
• Why women's health is decades behind: the research gap
• Dosed like a smaller man: why women get the wrong drug doses
• Why medicine is not one-size-fits-all for men and women

Sources

1. Zucker I, Prendergast BJ. Sex differences in pharmacokinetics predict adverse drug reactions in women. Biology of Sex Differences, 2020.
2. US General Accounting Office, Drug Safety: Most Drugs Withdrawn in Recent Years Had Greater Health Risks for Women, GAO-01-286R, January 2001.
3. Reviews describing the 1977 FDA guideline "General Considerations for the Clinical Evaluation of Drugs": Frontiers review, 2026 and review, 2014.
4. NIH Revitalization Act of 1993, Public Law 103-43, Section 131 (Section 492B of the Public Health Service Act). FDA, Study and Evaluation of Gender Differences in the Clinical Evaluation of Drugs (1993).

This article is for general education and is not medical advice. Sources were checked in October 2026. Several figures come from secondary analyses, as noted above.